NewAmsterdam Pharma Co N.V. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NewAmsterdam Pharma Co N.V. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2023 to Q3 2024.
  • NewAmsterdam Pharma Co N.V. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 94.8M shares, a 14.9% increase year-over-year.
  • NewAmsterdam Pharma Co N.V. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 82.2M shares, a 333% increase from 2022.
  • NewAmsterdam Pharma Co N.V. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 19M shares, a 72.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 94.8M +12.3M +14.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 94.7M +12.6M +15.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 88.4M +6.75M +8.26% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 82.2M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 82.5M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 82.1M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 81.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.